Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology
- 1 August 2007
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Nuclear Medicine Communications
- Vol. 28 (8), 589-595
- https://doi.org/10.1097/mnm.0b013e3281afa256
Abstract
To (a) assess the accuracy of 18F-FDG PET/CT in distinguishing malignant from benign pelvic lesions, compared to transvaginal ultrasonography (TVUS) and (b) to establish the role of whole-body 18F-FDG PET/CT, compared to contrast enhanced computed tomography (CT), in staging patients with ovarian cancer.Fifty consecutive patients with a pelvic lesion, already scheduled for surgery on the basis of physical examination, TVUS, and serum Ca125 levels, were enrolled in the study. Patients' age ranged between 23 and 89 years (mean 64). All patients underwent TVUS including a colour Doppler study followed by a thorax and abdominal CT scan, and whole-body 18F-FDG PET/CT within 2 weeks prior to surgery. Histological findings obtained at surgery were taken as the 'gold standard' to compare 18F-FDG PET/CT and TVUS, and 18F-FDG PET/CT vs. CT. When tissue analysis showed ovarian cancer, the accuracy of 18F-FDG PET/CT and CT were compared for the purpose of obtaining a precise staging.At surgery, the ovarian lesions were malignant in 32/50 patients (64%) and benign in the remaining 18/50 patients (36%). The sensitivity, specificity, NPV, PPV and accuracy of 18F-FDG PET/CT were 87%, 100%, 81%, 100% and 92%, respectively, compared with 90%, 61%, 78%, 80% and 80%, respectively, for TVUS. In staging ovarian cancer, 18F-FDG PET/CT results were concordant with final pathological staging in 22/32 (69%) patients while CT results were concordant in 17/32 (53%) patients. CT incorrectly down-staged four out of six stage IV patients by missing distant metastasis in the liver, pleura, mediastinum, and in left supraclavicular lymph nodes, which were correctly detected by 18F-FDG PET/CT.PET/CT with 18F-FDG provides additional value to TVUS for the differential diagnosis of benign from malignant pelvic lesions, and to CT for the staging of ovarian cancer patients.Keywords
This publication has 32 references indexed in Scilit:
- Early clinical detection of ovarian cancer: a review of the evidenceExpert Review of Anticancer Therapy, 2006
- Early diagnosis and predictors of malignancy of adnexal massesCurrent Opinion in Obstetrics and Gynecology, 2006
- Radiographic Imaging in Gynecologic OncologyClinical Obstetrics and Gynecology, 2001
- Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) groupUltrasound in Obstetrics & Gynecology, 2000
- Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter studyUltrasound in Obstetrics & Gynecology, 1997
- Controversies in Assessment of Ovarian Tumors with Transvaginal Color Doppler UltrasoundActa Obstetricia et Gynecologica Scandinavica, 1996
- Imaging of the ovary and adnexa: clinical issues and applications of MR imaging.Radiology, 1995
- Management of the Adnexal MassGynecologic Oncology, 1994
- Laparoscopic Management of Adnexal Cystic Masses in Postmenopausal WomenObstetrics & Gynecology, 1994
- Imaging in gynecologic malignanciesCancer, 1993